Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Founded in 2006 and based in Lund, Sweden, Clinical Laserthermia Systems AB (publ) specializes in crafting therapeutic instruments for treating diseased tissues, marketed under their TRANBERG brand. A core offering is the TRANBERG thermal therapy system, engineered to precisely deliver laser energy for heating targeted tissue. Their product range also features a mobile laser unit, an essential control component that operates at a 1064-nanometer wavelength, providing flexible options for treatment management. Additionally, the company supplies a variety of laser applicators in different gauges, alongside advanced devices for monitoring both temperature and the treatment's progress.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.